|
1
|
Haruhara K, Kanzaki G and Tsuboi N:
Nephrons, podocytes and chronic kidney disease: Strategic
antihypertensive therapy for renoprotection. Hypertens Res.
46:299–310. 2023.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bertram JF, Douglas-Denton RN, Diouf B,
Hughson MD and Hoy WE: Human nephron number: Implications for
health and disease. Pediatr Nephrol. 26:1529–1533. 2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Vivante A and Hildebrandt F: Exploring the
genetic basis of early-onset chronic kidney disease. Nat Rev
Nephrol. 12:133–146. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Mount DB: Thick ascending limb of the loop
of Henle. Clin J Am Soc Nephrol. 9:1974–1986. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Groopman EE, Marasa M, Cameron-Christie S,
Petrovski S, Aggarwal VS, Milo-Rasouly H, Li Y, Zhang J, Nestor J,
Krithivasan P, et al: Diagnostic utility of exome sequencing for
kidney disease. N Engl J Med. 380:142–151. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
KDIGO Conference Participants. Genetics in
chronic kidney disease: Conclusions from a Kidney Disease:
Improving Global Outcomes (KDIGO) Controversies Conference. Kidney
Int. 101:1126–1141. 2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Knoers N, Antignac C, Bergmann C, Dahan K,
Giglio S, Heidet L, Lipska-Ziętkiewicz BS, Noris M, Remuzzi G,
Vargas-Poussou R and Schaefer F: Genetic testing in the diagnosis
of chronic kidney disease: Recommendations for clinical practice.
Nephrol Dial Transplant. 37:239–254. 2022.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Jha V, Garcia-Garcia G, Iseki K, Li Z,
Naicker S, Plattner B, Saran R, Wang AY and Yang CW: Chronic kidney
disease: Global dimension and perspectives. Lancet. 382:260–272.
2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kovesdy CP: Epidemiology of chronic kidney
disease: An update 2022. Kidney Int Suppl (2011). 12:7–11.
2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
GBD 2023 Chronic Kidney Disease
Collaborators. Global, regional, and national burden of chronic
kidney disease in adults, 1990-2023, and its Attributable risk
factors: A systematic analysis for the Global burden of disease
study 2023. Lancet. 406:2461–2482. 2025.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Li Z, He R, Wang Y, Qu Z, Liu J, Yu R and
Yang S: Global trends of chronic kidney disease from 1990 to 2021:
A systematic analysis for the global burden of disease study 2021.
BMC Nephrol. 26(385)2025.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wilson HV: A new method by which sponges
may be artificially reared. Science. 25:912–915. 1907.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zwilling E: Development of fragmented and
of dissociated limb bud mesoderm. Dev Biol. 9:20–37.
1964.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Okabayashi K and Asashima M: In vitro
organogenesis using amphibian pluripotent cells. Proc Jpn Acad Ser
B Phys Biol Sci. 82:197–207. 2006.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Rheinwald JG and Green H: Serial
cultivation of strains of human epidermal keratinocytes: The
formation of keratinizing colonies from single cells. Cell.
6:331–343. 1975.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yu J, Vodyanik MA, Smuga-Otto K,
Antosiewicz-Bourget J, Frane JL, Tian S, Nie J, Jonsdottir GA,
Ruotti V, Stewart R, et al: Induced pluripotent stem cell lines
derived from human somatic cells. Science. 318:1917–1920.
2007.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Sato T, Vries RG, Snippert HJ, van de
Wetering M, Barker N, Stange DE, van Es JH, Abo A, Kujala P, Peters
PJ and Clevers H: Single Lgr5 stem cells build crypt-villus
structures in vitro without a mesenchymal niche. Nature.
459:262–265. 2009.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Han X, Cai C, Deng W, Shi Y, Li L, Wang C,
Zhang J, Rong M, Liu J, Fang B, et al: Landscape of human
organoids: Ideal model in clinics and research. Innovation (Camb).
5(100620)2024.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Barak H, Rosenfelder L, Schultheiss TM and
Reshef R: Cell fate specification along the anterior-posterior axis
of the intermediate mesoderm. Dev Dyn. 232:901–914. 2005.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Taguchi A, Kaku Y, Ohmori T, Sharmin S,
Ogawa M, Sasaki H and Nishinakamura R: Redefining the in vivo
origin of metanephric nephron progenitors enables generation of
complex kidney structures from pluripotent stem cells. Cell Stem
Cell. 14:53–67. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Majumdar A, Vainio S, Kispert A, McMahon J
and McMahon AP: Wnt11 and Ret/Gdnf pathways cooperate in regulating
ureteric branching during metanephric kidney development.
Development. 130:3175–3185. 2003.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kobayashi A, Valerius MT, Mugford JW,
Carroll TJ, Self M, Oliver G and McMahon AP: Six2 defines and
regulates a multipotent self-renewing nephron progenitor population
throughout mammalian kidney development. Cell Stem Cell. 3:169–181.
2008.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Grieshammer U, Cebrián C, Ilagan R, Meyers
E, Herzlinger D and Martin GR: FGF8 is required for cell survival
at distinct stages of nephrogenesis and for regulation of gene
expression in nascent nephrons. Development. 132:3847–3857.
2005.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Perantoni AO, Timofeeva O, Naillat F,
Richman C, Pajni-Underwood S, Wilson C, Vainio S, Dove LF and
Lewandoski M: Inactivation of FGF8 in early mesoderm reveals an
essential role in kidney development. Development. 132:3859–3871.
2005.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Georgas K, Rumballe B, Valerius MT, Chiu
HS, Thiagarajan RD, Lesieur E, Aronow BJ, Brunskill EW, Combes AN,
Tang D, et al: Analysis of early nephron patterning reveals a role
for distal RV proliferation in fusion to the ureteric tip via a cap
mesenchyme-derived connecting segment. Dev Biol. 332:273–286.
2009.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Halt K and Vainio S: Coordination of
kidney organogenesis by Wnt signaling. Pediatr Nephrol. 29:737–744.
2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Cheng HT, Kim M, Valerius MT, Surendran K,
Schuster-Gossler K, Gossler A, McMahon AP and Kopan R: Notch2, but
not Notch1, is required for proximal fate acquisition in the
mammalian nephron. Development. 134:801–811. 2007.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kretzler M, Schröppel B, Merkle M, Huber
S, Mundel P, Horster M and Schlöndorff D: Detection of multiple
vascular endothelial growth factor splice isoforms in single
glomerular podocytes. Kidney Int Suppl. 67 (Suppl 1):S159–S161.
1998.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Schell C, Wanner N and Huber TB:
Glomerular development-shaping the multi-cellular filtration unit.
Semin Cell Dev Biol. 36:39–49. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Lindahl P, Hellström M, Kalén M, Karlsson
L, Pekny M, Pekna M, Soriano P and Betsholtz C: Paracrine
PDGF-B/PDGF-Rbeta signaling controls mesangial cell development in
kidney glomeruli. Development. 125:3313–3322. 1998.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Little M, Georgas K, Pennisi D and
Wilkinson L: Kidney development: Two tales of tubulogenesis. Curr
Top Dev Biol. 90:193–229. 2010.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Faa G, Gerosa C, Fanni D, Monga G,
Zaffanello M, Van Eyken P and Fanos V: Morphogenesis and molecular
mechanisms involved in human kidney development. J Cell Physiol.
227:1257–1268. 2012.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Little MH, Kumar SV and Forbes T:
Recapitulating kidney development: Progress and challenges. Semin
Cell Dev Biol. 91:153–168. 2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Humphreys BD, Lin SL, Kobayashi A, Hudson
TE, Nowlin BT, Bonventre JV, Valerius MT, McMahon AP and Duffield
JS: Fate tracing reveals the pericyte and not epithelial origin of
myofibroblasts in kidney fibrosis. Am J Pathol. 176:85–97.
2010.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Bohnenpoll T, Bettenhausen E, Weiss AC,
Foik AB, Trowe MO, Blank P, Airik R and Kispert A: Tbx18 expression
demarcates multipotent precursor populations in the developing
urogenital system but is exclusively required within the ureteric
mesenchymal lineage to suppress a renal stromal fate. Dev Biol.
380:25–36. 2013.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Li W, Hartwig S and Rosenblum ND:
Developmental origins and functions of stromal cells in the normal
and diseased mammalian kidney. Dev Dyn. 243:853–863.
2014.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Kobayashi A, Mugford JW, Krautzberger AM,
Naiman N, Liao J and McMahon AP: Identification of a multipotent
self-renewing stromal progenitor population during mammalian kidney
organogenesis. Stem Cell Rep. 3:650–662. 2014.PubMed/NCBI View Article : Google Scholar
|
|
38
|
McMahon AP: Development of the mammalian
kidney. Curr Top Dev Biol. 117:31–64. 2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Rowan CJ, Sheybani-Deloui S and Rosenblum
ND: Origin and function of the renal stroma in health and disease.
Results Probl Cell Differ. 60:205–229. 2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Fusco AN, Oxburgh L and Carroll TJ: The
kidney stroma in development and disease. Nat Rev Nephrol.
21:756–777. 2025.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Magella B, Adam M, Potter AS,
Venkatasubramanian M, Chetal K, Hay SB, Salomonis N and Potter SS:
Cross-platform single cell analysis of kidney development shows
stromal cells express Gdnf. Dev Biol. 434:36–47. 2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Morizane R, Lam AQ, Freedman BS, Kishi S,
Valerius MT and Bonventre JV: Nephron organoids derived from human
pluripotent stem cells model kidney development and injury. Nat
Biotechnol. 33:1193–1200. 2015.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Takasato M, Er PX, Chiu HS, Maier B,
Baillie GJ, Ferguson C, Parton RG, Wolvetang EJ, Roost MS, Chuva de
Sousa Lopes SM and Little MH: Kidney organoids from human iPS cells
contain multiple lineages and model human nephrogenesis. Nature.
526:564–568. 2015.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Wu H, Uchimura K, Donnelly EL, Kirita Y,
Morris SA and Humphreys BD: Comparative analysis and refinement of
human PSC-Derived kidney organoid differentiation with Single-cell
transcriptomics. Cell Stem Cell. 23:869–881.e8. 2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Freedman BS, Brooks CR, Lam AQ, Fu H,
Morizane R, Agrawal V, Saad AF, Li MK, Hughes MR, Werff RV, et al:
Modelling kidney disease with CRISPR-mutant kidney organoids
derived from human pluripotent epiblast spheroids. Nat Commun.
6(8715)2015.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Low JH, Li P, Chew EGY, Zhou B, Suzuki K,
Zhang T, Lian MM, Liu M, Aizawa E, Rodriguez Esteban C, et al:
Generation of human PSC-derived kidney organoids with patterned
nephron segments and a de novo vascular network. Cell Stem Cell.
25:373–387.e9. 2019.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Taguchi A and Nishinakamura R:
Higher-order kidney organogenesis from pluripotent stem cells. Cell
Stem Cell. 21:730–746.e6. 2017.PubMed/NCBI View Article : Google Scholar
|
|
48
|
van den Berg CW, Ritsma L, Avramut MC,
Wiersma LE, van den Berg BM, Leuning DG, Lievers E, Koning M,
Vanslambrouck JM, Koster AJ, et al: Renal subcapsular
transplantation of PSC-Derived kidney organoids induces
Neo-vasculogenesis and significant glomerular and tubular
maturation in vivo. Stem Cell Reports. 10:751–765. 2018.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Shi M, Crouse B, Sundaram N, Pode Shakked
N, Thorner K, King NM, Dutta P, Ester L, Zhang W, Govindarajah V,
et al: Integrating collecting systems in human kidney organoids
through fusion of distal nephron to ureteric bud. Cell Stem Cell.
32:1055–1070.e8. 2025.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Cruz NM, Song X, Czerniecki SM, Gulieva
RE, Churchill AJ, Kim YK, Winston K, Tran LM, Diaz MA, Fu H, et al:
Organoid cystogenesis reveals a critical role of microenvironment
in human polycystic kidney disease. Nat Mater. 16:1112–1119.
2017.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Forbes TA, Howden SE, Lawlor K, Phipson B,
Maksimovic J, Hale L, Wilson S, Quinlan C, Ho G, Holman K, et al:
Patient-iPSC-derived kidney organoids show functional validation of
a ciliopathic renal phenotype and reveal underlying pathogenetic
mechanisms. Am J Hum Genet. 102:816–831. 2018.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Czerniecki SM, Cruz NM, Harder JL, Menon
R, Annis J, Otto EA, Gulieva RE, Islas LV, Kim YK, Tran LM, et al:
High-throughput screening enhances kidney organoid differentiation
from human pluripotent stem cells and enables automated
multidimensional phenotyping. Cell Stem Cell. 22:929–940.e4.
2018.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Cornec-Le Gall E, Torres VE and Harris PC:
Genetic complexity of autosomal dominant polycystic kidney and
liver diseases. J Am Soc Nephrol. 29:13–23. 2018.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Xu Y, Kuppe C, Perales-Patón J, Hayat S,
Kranz J, Abdallah AT, Nagai J, Li Z, Peisker F, Saritas T, et al:
Adult human kidney organoids originate from CD24+ cells and
represent an advanced model for adult polycystic kidney disease.
Nat Genet. 54:1690–1701. 2022.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Vishy CE, Thomas C, Vincent T, Crawford
DK, Goddeeris MM and Freedman BS: Genetics of cystogenesis in
base-edited human organoids reveal therapeutic strategies for
polycystic kidney disease. Cell Stem Cell. 31:537–553.e5.
2024.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Cordido A, Vizoso-Gonzalez M and
Garcia-Gonzalez MA: Molecular pathophysiology of autosomal
recessive polycystic kidney disease. Int J Mol Sci.
22(6523)2021.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Lu H, Galeano MCR, Ott E, Kaeslin G,
Kausalya PJ, Kramer C, Ortiz-Brüchle N, Hilger N, Metzis V,
Hiersche M, et al: Mutations in DZIP1L, which encodes a
ciliary-transition-zone protein, cause autosomal recessive
polycystic kidney disease. Nat Genet. 49:1025–1034. 2017.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Goggolidou P and Richards T: The genetics
of autosomal recessive polycystic kidney disease (ARPKD). Biochim
Biophys Acta Mol Basis Dis. 1868(166348)2022.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Bergmann C, Guay-Woodford LM, Harris PC,
Horie S, Peters DJM and Torres VE: Polycystic kidney disease. Nat
Rev Dis Primers. 4(50)2018.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Guay-Woodford LM, Muecher G, Hopkins SD,
Avner ED, Germino GG, Guillot AP, Herrin J, Holleman R, Irons DA,
Primack W, et al: The severe perinatal form of autosomal recessive
polycystic kidney disease maps to chromosome 6p21.1-p12:
Implications for genetic counseling. Am J Hum Genet. 56:1101–1107.
1995.PubMed/NCBI
|
|
61
|
Hiratsuka K, Miyoshi T, Kroll KT, Gupta
NR, Valerius MT, Ferrante T, Yamashita M, Lewis JA and Morizane R:
Organoid-on-a-chip model of human ARPKD reveals mechanosensing
pathomechanisms for drug discovery. Sci Adv.
8(eabq0866)2022.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Ohshima T, Murray GJ, Swaim WD,
Longenecker G, Quirk JM, Cardarelli CO, Sugimoto Y, Pastan I,
Gottesman MM, Brady RO and Kulkarni AB: alpha-Galactosidase A
deficient mice: A model of Fabry disease. Proc Natl Acad Sci USA.
94:2540–2544. 1997.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Porto C, Pisani A, Rosa M, Acampora E,
Avolio V, Tuzzi MR, Visciano B, Gagliardo C, Materazzi S, la Marca
G, et al: Synergy between the pharmacological chaperone
1-deoxygalactonojirimycin and the human recombinant
alpha-galactosidase A in cultured fibroblasts from patients with
Fabry disease. J Inherit Metab Dis. 35:513–520. 2012.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Cui S, Shin YJ, Fang X, Lee H, Eum SH, Ko
EJ, Lim SW, Shin E, Lee KI, Lee JY, et al: CRISPR/Cas9-mediated
A4GALT suppression rescues Fabry disease phenotypes in a kidney
organoid model. Transl Res. 258:35–46. 2023.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Cui S, Fang X, Lee H, Shin YJ, Koh ES,
Chung S, Park HS, Lim SW, Lee KI, Lee JY, et al: Modeling of Fabry
disease nephropathy using patient derived human induced pluripotent
stem cells and kidney organoid system. J Transl Med.
21(138)2023.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Lim SW, Shin YJ, Cui S, Ko EJ, Lee KI, Lee
JY, Chung BH and Yang CW: Generation of a human induced pluripotent
stem cell line (CMCi002-A) from a patient with Gitelman's syndrome.
Stem Cell Res. 49(102110)2020.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Lim SW, Fang X, Cui S, Lee H, Shin YJ, Ko
EJ, Lee KI, Lee JY, Chung BH and Yang CW: CRISPR-Cas9-Mediated
correction of SLC12A3 gene mutation rescues the Gitelman's disease
phenotype in a Patient-derived kidney organoid system. Int J Mol
Sci. 24(3019)2023.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Przepiorski A, Sander V, Tran T, Hollywood
JA, Sorrenson B, Shih JH, Wolvetang EJ, McMahon AP, Holm TM and
Davidson AJ: A simple Bioreactor-based method to generate kidney
organoids from pluripotent stem cells. Stem Cell Reports.
11:470–484. 2018.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Kim JW, Kim HW, Nam SA, Lee JY, Cho HJ,
Kim TM and Kim YK: Human kidney organoids reveal the role of
glutathione in Fabry disease. Exp Mol Med. 53:1580–1591.
2021.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Burry AF: Extreme dysplasia in renal
epithelium of a young woman dying from hepatocarcinoma. J Pathol.
113:147–150. 1974.PubMed/NCBI View Article : Google Scholar
|
|
71
|
El-Husseiny Moustafa F, Nagy E, Elwasif SM
and Sobh M: Karyomegalic interstitial nephritis as a rare cause of
kidney graft dysfunction: Case report and review of literature. BMC
Nephrol. 24(137)2023.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Zhou W, Otto EA, Cluckey A, Airik R, Hurd
TW, Chaki M, Diaz K, Lach FP, Bennett GR, Gee HY, et al: FAN1
mutations cause karyomegalic interstitial nephritis, linking
chronic kidney failure to defective DNA damage repair. Nat Genet.
44:910–915. 2012.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Lim SW, Na D, Lee H, Fang X, Cui S, Shin
YJ, Lee KI, Lee JY, Yang CW and Chung BH: Modeling of
FAN1-Deficient kidney disease using a human induced pluripotent
stem Cell-derived kidney organoid system. Cells.
12(2319)2023.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Gitelman HJ, Graham JB and Welt LG: A new
familial disorder characterized by hypokalemia and hypomagnesemia.
Trans Assoc Am Physicians. 79:221–235. 1966.PubMed/NCBI
|
|
75
|
Blanchard A, Bockenhauer D, Bolignano D,
Calò LA, Cosyns E, Devuyst O, Ellison DH, Karet Frankl FE, Knoers
NV, Konrad M, et al: Gitelman syndrome: Consensus and guidance from
a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies
Conference. Kidney Int. 91:24–33. 2017.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Kashtan CE: Alport syndrome: Achieving
early diagnosis and treatment. Am J Kidney Dis. 77:272–279.
2021.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Jefferson JA, Lemmink HH, Hughes AE, Hill
CM, Smeets HJ, Doherty CC and Maxwell AP: Autosomal dominant Alport
syndrome linked to the type IV collage alpha 3 and alpha 4 genes
(COL4A3 and COL4A4). Nephrol Dial Transplant. 12:1595–1599.
1997.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Bekheirnia MR, Reed B, Gregory MC, McFann
K, Shamshirsaz AA, Masoumi A and Schrier RW: Genotype-phenotype
correlation in X-linked Alport syndrome. J Am Soc Nephrol.
21:876–883. 2010.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Lennon R, Byron A, Humphries JD, Randles
MJ, Carisey A, Murphy S, Knight D, Brenchley PE, Zent R and
Humphries MJ: Global analysis reveals the complexity of the human
glomerular extracellular matrix. J Am Soc Nephrol. 25:939–951.
2014.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Hirayama R, Toyohara K, Watanabe K, Otsuki
T, Araoka T, Mae SI, Horinouchi T, Yamamura T, Okita K, Hotta A, et
al: iPSC-derived type IV collagen α5-expressing kidney organoids
model Alport syndrome. Commun Biol. 6(854)2023.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Morais M, Tian P, Lawless C, Murtuza-Baker
S, Hopkinson L, Woods S, Mironov A, Long DA, Gale DP, Zorn TMT, et
al: Kidney organoids recapitulate human basement membrane assembly
in health and disease. Elife. 11(e73486)2022.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Veissi S, Smeets B, van den Heuvel LP,
Schreuder MF and Jansen J: Nephrotic syndrome in a dish: Recent
developments in modeling in vitro. Pediatr Nephrol. 35:1363–1372.
2020.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Shabaka A, Tato Ribera A and
Fernández-Juárez G: Focal segmental glomerulosclerosis:
State-of-the-Art and clinical perspective. Nephron. 144:413–427.
2020.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Tanigawa S, Islam M, Sharmin S, Naganuma
H, Yoshimura Y, Haque F, Era T, Nakazato H, Nakanishi K, Sakuma T,
et al: Organoids from nephrotic Disease-derived iPSCs identify
impaired NEPHRIN localization and slit diaphragm formation in
kidney podocytes. Stem Cell Reports. 11:727–740. 2018.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Ohmori T, De S, Tanigawa S, Miike K, Islam
M, Soga M, Era T, Shiona S, Nakanishi K, Nakazato H and
Nishinakamura R: Impaired NEPHRIN localization in kidney organoids
derived from nephrotic patient iPS cells. Sci Rep.
11(3982)2021.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Jansen J, van den Berge BT, van den Broek
M, Maas RJ, Daviran D, Willemsen B, Roverts R, van der Kruit M,
Kuppe C, Reimer KC, et al: Human pluripotent stem cell-derived
kidney organoids for personalized congenital and idiopathic
nephrotic syndrome modeling. Development.
149(dev200198)2022.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Majmundar AJ, Buerger F, Forbes TA, Klämbt
V, Schneider R, Deutsch K, Kitzler TM, Howden SE, Scurr M, Tan KS,
et al: Recessive NOS1AP variants impair actin remodeling and cause
glomerulopathy in humans and mice. Sci Adv.
7(eabe1386)2021.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Devuyst O, Olinger E, Weber S, Eckardt KU,
Kmoch S, Rampoldi L and Bleyer AJ: Autosomal dominant
tubulointerstitial kidney disease. Nat Rev Dis Primers.
5(60)2019.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Eckardt KU, Alper SL, Antignac C, Bleyer
AJ, Chauveau D, Dahan K, Deltas C, Hosking A, Kmoch S, Rampoldi L,
et al: Autosomal dominant tubulointerstitial kidney disease:
Diagnosis, classification, and management-A KDIGO consensus report.
Kidney Int. 88:676–683. 2015.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Mae SI, Ryosaka M, Sakamoto S, Matsuse K,
Nozaki A, Igami M, Kabai R, Watanabe A and Osafune K: Expansion of
Human iPSC-derived ureteric bud organoids with repeated branching
potential. Cell Rep. 32(107963)2020.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Dvela-Levitt M, Kost-Alimova M, Emani M,
Kohnert E, Thompson R, Sidhom EH, Rivadeneira A, Sahakian N,
Roignot J, Papagregoriou G, et al: Small molecule targets TMED9 and
promotes lysosomal degradation to reverse proteinopathy. Cell.
178:521–535.e23. 2019.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Gubler MC and Antignac C:
Renin-angiotensin system in kidney development: Renal tubular
dysgenesis. Kidney Int. 77:400–406. 2010.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Pode-Shakked N, Slack M, Sundaram N,
Schreiber R, McCracken KW, Dekel B, Helmrath M and Kopan R:
RAAS-deficient organoids indicate delayed angiogenesis as a
possible cause for autosomal recessive renal tubular dysgenesis.
Nat Commun. 14(8159)2023.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Wolf MTF, Bonsib SM, Larsen CP and
Hildebrandt F: Nephronophthisis: A pathological and genetic
perspective. Pediatr Nephrol. 39:1977–2000. 2024.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Perrault I, Saunier S, Hanein S, Filhol E,
Bizet AA, Collins F, Salih MA, Gerber S, Delphin N, Bigot K, et al:
Mainzer-Saldino syndrome is a ciliopathy caused by IFT140
mutations. Am J Hum Genet. 90:864–870. 2012.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Schmidts M, Frank V, Eisenberger T, Al
Turki S, Bizet AA, Antony D, Rix S, Decker C, Bachmann N, Bald M,
et al: Combined NGS approaches identify mutations in the
intraflagellar transport gene IFT140 in skeletal ciliopathies with
early progressive kidney disease. Hum Mutat. 34:714–724.
2013.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Nesterova G and Gahl WA: Cystinosis: The
evolution of a treatable disease. Pediatr Nephrol. 28:51–59.
2013.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Hollywood JA, Przepiorski A, D'Souza RF,
Sreebhavan S, Wolvetang EJ, Harrison PT, Davidson AJ and Holm TM:
Use of human induced pluripotent stem cells and kidney organoids to
develop a Cysteamine/mTOR inhibition combination therapy for
cystinosis. J Am Soc Nephrol. 31:962–982. 2020.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Ceccotti E, Semnani A, Bussolati B and
Bruno S: Human kidney organoids for modeling the development of
different diseases. Curr Top Dev Biol. 163:364–393. 2025.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Koning M, Dumas SJ, Avramut MC, Koning RI,
Meta E, Lievers E, Wiersma LE, Borri M, Liang X, Xie L, et al:
Vasculogenesis in kidney organoids upon transplantation. NPJ Regen
Med. 7(40)2022.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Lim D, Kim I, Song Q, Kim JH, Atala A,
Jackson JD and Yoo JJ: Development and intra-renal delivery of
renal progenitor organoids for effective integration in vivo. Stem
Cells Transl Med. 14(szae078)2025.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Homan KA, Gupta N, Kroll KT, Kolesky DB,
Skylar-Scott M, Miyoshi T, Mau D, Valerius MT, Ferrante T,
Bonventre JV, et al: Flow-enhanced vascularization and maturation
of kidney organoids in vitro. Nat Methods. 16:255–262.
2019.PubMed/NCBI View Article : Google Scholar
|
|
103
|
Petrosyan A, Cravedi P, Villani V,
Angeletti A, Manrique J, Renieri A, De Filippo RE, Perin L and Da
Sacco S: A glomerulus-on-a-chip to recapitulate the human
glomerular filtration barrier. Nat Commun. 10(3656)2019.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Weber EJ, Chapron A, Chapron BD,
Voellinger JL, Lidberg KA, Yeung CK, Wang Z, Yamaura Y, Hailey DW,
Neumann T, et al: Development of a microphysiological model of
human kidney proximal tubule function. Kidney Int. 90:627–637.
2016.PubMed/NCBI View Article : Google Scholar
|
|
105
|
Li SR, Gulieva RE, Helms L, Cruz NM,
Vincent T, Fu H, Himmelfarb J and Freedman BS: Glucose absorption
drives cystogenesis in a human organoid-on-chip model of polycystic
kidney disease. Nat Commun. 13(7918)2022.PubMed/NCBI View Article : Google Scholar
|
|
106
|
Vormann MK, Gijzen L, Hutter S, Boot L,
Nicolas A, van den Heuvel A, Vriend J, Ng CP, Nieskens TTG, van
Duinen V, et al: Nephrotoxicity and kidney transport assessment on
3D perfused proximal tubules. AAPS J. 20(90)2018.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Ingber DE: Human organs-on-chips for
disease modelling, drug development and personalized medicine. Nat
Rev Genet. 23:467–491. 2022.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Grange C and Bussolati B: Extracellular
vesicles in kidney disease. Nat Rev Nephrol. 18:499–513.
2022.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Grange C, Skovronova R, Marabese F and
Bussolati B: Stem Cell-derived extracellular vesicles and kidney
regeneration. Cells. 8(1240)2019.PubMed/NCBI View Article : Google Scholar
|
|
110
|
Bruno S, Grange C, Deregibus MC, Calogero
RA, Saviozzi S, Collino F, Morando L, Busca A, Falda M, Bussolati
B, et al: Mesenchymal stem cell-derived microvesicles protect
against acute tubular injury. J Am Soc Nephrol. 20:1053–1067.
2009.PubMed/NCBI View Article : Google Scholar
|
|
111
|
Trush O and Takasato M: Kidney organoid
research: Current status and applications. Curr Opin Genet Dev.
75(101944)2022.PubMed/NCBI View Article : Google Scholar
|
|
112
|
Karp S, Pollak MR and Subramanian B:
Disease modeling with kidney organoids. Micromachines (Basel).
13(1384)2022.PubMed/NCBI View Article : Google Scholar
|
|
113
|
Tekguc M, Gaal RCV, Uzel SGM, Gupta N,
Riella LV, Lewis JA and Morizane R: Kidney organoids: A pioneering
model for kidney diseases. Transl Res. 250:1–17. 2022.PubMed/NCBI View Article : Google Scholar
|
|
114
|
Liu M, Cardilla A, Ngeow J, Gong X and Xia
Y: Studying kidney diseases using organoid models. Front Cell Dev
Biol. 10(845401)2022.PubMed/NCBI View Article : Google Scholar
|
|
115
|
England AR, Chaney CP, Das A, Patel M,
Malewska A, Armendariz D, Hon GC, Strand DW, Drake KA and Carroll
TJ: Identification and characterization of cellular heterogeneity
within the developing renal interstitium. Development.
147(dev190108)2020.PubMed/NCBI View Article : Google Scholar
|
|
116
|
Shankar AS, Tejeda-Mora H, Du Z, Nlandu Q,
Palomares-Cabeza V, van den Bosch TPP, Korevaar SS, Da Costa
Gonçalves F, Bindels EMJ, Kramann R, et al: Interactions of the
immune system with human kidney organoids. Transpl Int.
37(12468)2024.PubMed/NCBI View Article : Google Scholar
|
|
117
|
Rizki-Safitri A, Traitteur T and Morizane
R: Bioengineered kidney models: Methods and functional assessments.
Function (Oxf). 2(zqab026)2021.PubMed/NCBI View Article : Google Scholar
|
|
118
|
Romero-Guevara R, Ioannides A and Xinaris
C: Kidney organoids as disease models: Strengths, weaknesses and
perspectives. Front Physiol. 11(563981)2020.PubMed/NCBI View Article : Google Scholar
|
|
119
|
Hu C, Yang S, Zhang T, Ge Y, Chen Z, Zhang
J, Pu Y and Liang G: Organoids and organoids-on-a-chip as the new
testing strategies for environmental toxicology-applications &
advantages. Environ Int. 184(108415)2024.PubMed/NCBI View Article : Google Scholar
|
|
120
|
Song SS, Park HJ, Kim YK and Kang SW:
Revolutionizing biomedical research: The imperative need for
heart-kidney-connected organoids. APL Bioeng.
8(010902)2024.PubMed/NCBI View Article : Google Scholar
|
|
121
|
Lawlor KT, Vanslambrouck JM, Higgins JW,
Chambon A, Bishard K, Arndt D, Er PX, Wilson SB, Howden SE, Tan KS,
et al: Cellular extrusion bioprinting improves kidney organoid
reproducibility and conformation. Nat Mater. 20:260–271.
2021.PubMed/NCBI View Article : Google Scholar
|
|
122
|
Shin J, Chung H, Kumar H, Meadows K, Park
S, Chun J and Kim K: 3D bioprinting of human iPSC-derived kidney
organoids using a low-cost, high-throughput customizable 3D
bioprinting system. Bioprinting. 38(e00337)2024.
|
|
123
|
Vanslambrouck JM, Wilson SB, Tan KS,
Groenewegen E, Rudraraju R, Neil J, Lawlor KT, Mah S, Scurr M,
Howden SE, et al: Enhanced metanephric specification to functional
proximal tubule enables toxicity screening and infectious disease
modelling in kidney organoids. Nat Commun. 13(5943)2022.PubMed/NCBI View Article : Google Scholar
|
|
124
|
Schutgens F, Rookmaaker MB, Margaritis T,
Rios A, Ammerlaan C, Jansen J, Gijzen L, Vormann M, Vonk A, Viveen
M, et al: Tubuloids derived from human adult kidney and urine for
personalized disease modeling. Nat Biotechnol. 37:303–313.
2019.PubMed/NCBI View Article : Google Scholar
|
